Global Biosimilar Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biosimilar market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
Unlike with generic drugs of the more common small-molecule type, biologics generally exhibit high molecular complexity and may be quite sensitive to changes in manufacturing processes. Despite that heterogeneity, all biopharmaceuticals, including biosimilar, must maintain consistent quality and clinical performance throughout their lifecycle.
In this report is a biologic defined as proteins, peptides, hormones or antibody’s drugs production by bio-engineered technology, but does not include a vaccine.
China’s core biosimilar players include Qilu Pharmaceutical, Shanghai Henlius and 3SBIO etc. The top 3 companies only hold a share about 61%.
In terms of product, biosimilar monoclonal antibodies is the largest segment, with a share about 85%. And in terms of application, the largest application is cancer?with a share about 50%.
The Global Info Research report includes an overview of the development of the Biosimilar industry chain, the market status of Cancer (Biosimilar Monoclonal Antibodies, Biosimilar Insulin), Immunological Diseases (Biosimilar Monoclonal Antibodies, Biosimilar Insulin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilar.
Regionally, the report analyzes the Biosimilar markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilar market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilar market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilar industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biosimilar Monoclonal Antibodies, Biosimilar Insulin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilar market.
Regional Analysis: The report involves examining the Biosimilar market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilar market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilar:
Company Analysis: Report covers individual Biosimilar players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilar This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Immunological Diseases).
Technology Analysis: Report covers specific technologies relevant to Biosimilar. It assesses the current state, advancements, and potential future developments in Biosimilar areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilar market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilar market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Biosimilar product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilar, with revenue, gross margin and global market share of Biosimilar from 2019 to 2024.
Chapter 3, the Biosimilar competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biosimilar market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar.
Chapter 13, to describe Biosimilar research findings and conclusion.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
Unlike with generic drugs of the more common small-molecule type, biologics generally exhibit high molecular complexity and may be quite sensitive to changes in manufacturing processes. Despite that heterogeneity, all biopharmaceuticals, including biosimilar, must maintain consistent quality and clinical performance throughout their lifecycle.
In this report is a biologic defined as proteins, peptides, hormones or antibody’s drugs production by bio-engineered technology, but does not include a vaccine.
China’s core biosimilar players include Qilu Pharmaceutical, Shanghai Henlius and 3SBIO etc. The top 3 companies only hold a share about 61%.
In terms of product, biosimilar monoclonal antibodies is the largest segment, with a share about 85%. And in terms of application, the largest application is cancer?with a share about 50%.
The Global Info Research report includes an overview of the development of the Biosimilar industry chain, the market status of Cancer (Biosimilar Monoclonal Antibodies, Biosimilar Insulin), Immunological Diseases (Biosimilar Monoclonal Antibodies, Biosimilar Insulin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilar.
Regionally, the report analyzes the Biosimilar markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilar market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilar market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilar industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biosimilar Monoclonal Antibodies, Biosimilar Insulin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilar market.
Regional Analysis: The report involves examining the Biosimilar market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilar market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilar:
Company Analysis: Report covers individual Biosimilar players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilar This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Immunological Diseases).
Technology Analysis: Report covers specific technologies relevant to Biosimilar. It assesses the current state, advancements, and potential future developments in Biosimilar areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilar market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilar market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Biosimilar Monoclonal Antibodies
- Biosimilar Insulin
- Others
- Cancer
- Immunological Diseases
- Diabetes
- Others
- Pfizer
- Amgen
- Biogen
- Novartis
- Samsung Bioepis
- Viatris
- Fresenius Kabi
- Celltrion
- Cadila Healthcare
- Torrent Pharmaceuticals
- Boehringer Ingelheim
- Qilu Pharmaceutical
- Bio-Thera
- Zhejiang Hisun
- Shanghai Henlius
- Innovent Biologics
- Jiangsu Hengrui
- Gan&Lee
- Tonghua Dongbao
- United Laboratory
- 3SBIO
- Luye Pharma
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biosimilar product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilar, with revenue, gross margin and global market share of Biosimilar from 2019 to 2024.
Chapter 3, the Biosimilar competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biosimilar market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar.
Chapter 13, to describe Biosimilar research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilar
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilar by Type
1.3.1 Overview: Global Biosimilar Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biosimilar Consumption Value Market Share by Type in 2023
1.3.3 Biosimilar Monoclonal Antibodies
1.3.4 Biosimilar Insulin
1.3.5 Others
1.4 Global Biosimilar Market by Application
1.4.1 Overview: Global Biosimilar Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer
1.4.3 Immunological Diseases
1.4.4 Diabetes
1.4.5 Others
1.5 Global Biosimilar Market Size & Forecast
1.6 Global Biosimilar Market Size and Forecast by Region
1.6.1 Global Biosimilar Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biosimilar Market Size by Region, (2019-2030)
1.6.3 North America Biosimilar Market Size and Prospect (2019-2030)
1.6.4 Europe Biosimilar Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biosimilar Market Size and Prospect (2019-2030)
1.6.6 South America Biosimilar Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biosimilar Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biosimilar Product and Solutions
2.1.4 Pfizer Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biosimilar Product and Solutions
2.2.4 Amgen Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Biosimilar Product and Solutions
2.3.4 Biogen Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Biosimilar Product and Solutions
2.4.4 Novartis Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Samsung Bioepis
2.5.1 Samsung Bioepis Details
2.5.2 Samsung Bioepis Major Business
2.5.3 Samsung Bioepis Biosimilar Product and Solutions
2.5.4 Samsung Bioepis Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Samsung Bioepis Recent Developments and Future Plans
2.6 Viatris
2.6.1 Viatris Details
2.6.2 Viatris Major Business
2.6.3 Viatris Biosimilar Product and Solutions
2.6.4 Viatris Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Viatris Recent Developments and Future Plans
2.7 Fresenius Kabi
2.7.1 Fresenius Kabi Details
2.7.2 Fresenius Kabi Major Business
2.7.3 Fresenius Kabi Biosimilar Product and Solutions
2.7.4 Fresenius Kabi Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Fresenius Kabi Recent Developments and Future Plans
2.8 Celltrion
2.8.1 Celltrion Details
2.8.2 Celltrion Major Business
2.8.3 Celltrion Biosimilar Product and Solutions
2.8.4 Celltrion Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Celltrion Recent Developments and Future Plans
2.9 Cadila Healthcare
2.9.1 Cadila Healthcare Details
2.9.2 Cadila Healthcare Major Business
2.9.3 Cadila Healthcare Biosimilar Product and Solutions
2.9.4 Cadila Healthcare Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Cadila Healthcare Recent Developments and Future Plans
2.10 Torrent Pharmaceuticals
2.10.1 Torrent Pharmaceuticals Details
2.10.2 Torrent Pharmaceuticals Major Business
2.10.3 Torrent Pharmaceuticals Biosimilar Product and Solutions
2.10.4 Torrent Pharmaceuticals Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Torrent Pharmaceuticals Recent Developments and Future Plans
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim Biosimilar Product and Solutions
2.11.4 Boehringer Ingelheim Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Boehringer Ingelheim Recent Developments and Future Plans
2.12 Qilu Pharmaceutical
2.12.1 Qilu Pharmaceutical Details
2.12.2 Qilu Pharmaceutical Major Business
2.12.3 Qilu Pharmaceutical Biosimilar Product and Solutions
2.12.4 Qilu Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Qilu Pharmaceutical Recent Developments and Future Plans
2.13 Bio-Thera
2.13.1 Bio-Thera Details
2.13.2 Bio-Thera Major Business
2.13.3 Bio-Thera Biosimilar Product and Solutions
2.13.4 Bio-Thera Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Bio-Thera Recent Developments and Future Plans
2.14 Zhejiang Hisun
2.14.1 Zhejiang Hisun Details
2.14.2 Zhejiang Hisun Major Business
2.14.3 Zhejiang Hisun Biosimilar Product and Solutions
2.14.4 Zhejiang Hisun Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Zhejiang Hisun Recent Developments and Future Plans
2.15 Shanghai Henlius
2.15.1 Shanghai Henlius Details
2.15.2 Shanghai Henlius Major Business
2.15.3 Shanghai Henlius Biosimilar Product and Solutions
2.15.4 Shanghai Henlius Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Shanghai Henlius Recent Developments and Future Plans
2.16 Innovent Biologics
2.16.1 Innovent Biologics Details
2.16.2 Innovent Biologics Major Business
2.16.3 Innovent Biologics Biosimilar Product and Solutions
2.16.4 Innovent Biologics Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Innovent Biologics Recent Developments and Future Plans
2.17 Jiangsu Hengrui
2.17.1 Jiangsu Hengrui Details
2.17.2 Jiangsu Hengrui Major Business
2.17.3 Jiangsu Hengrui Biosimilar Product and Solutions
2.17.4 Jiangsu Hengrui Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Jiangsu Hengrui Recent Developments and Future Plans
2.18 Gan&Lee
2.18.1 Gan&Lee Details
2.18.2 Gan&Lee Major Business
2.18.3 Gan&Lee Biosimilar Product and Solutions
2.18.4 Gan&Lee Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Gan&Lee Recent Developments and Future Plans
2.19 Tonghua Dongbao
2.19.1 Tonghua Dongbao Details
2.19.2 Tonghua Dongbao Major Business
2.19.3 Tonghua Dongbao Biosimilar Product and Solutions
2.19.4 Tonghua Dongbao Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Tonghua Dongbao Recent Developments and Future Plans
2.20 United Laboratory
2.20.1 United Laboratory Details
2.20.2 United Laboratory Major Business
2.20.3 United Laboratory Biosimilar Product and Solutions
2.20.4 United Laboratory Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 United Laboratory Recent Developments and Future Plans
2.21 3SBIO
2.21.1 3SBIO Details
2.21.2 3SBIO Major Business
2.21.3 3SBIO Biosimilar Product and Solutions
2.21.4 3SBIO Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 3SBIO Recent Developments and Future Plans
2.22 Luye Pharma
2.22.1 Luye Pharma Details
2.22.2 Luye Pharma Major Business
2.22.3 Luye Pharma Biosimilar Product and Solutions
2.22.4 Luye Pharma Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Luye Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilar Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biosimilar by Company Revenue
3.2.2 Top 3 Biosimilar Players Market Share in 2023
3.2.3 Top 6 Biosimilar Players Market Share in 2023
3.3 Biosimilar Market: Overall Company Footprint Analysis
3.3.1 Biosimilar Market: Region Footprint
3.3.2 Biosimilar Market: Company Product Type Footprint
3.3.3 Biosimilar Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilar Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biosimilar Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilar Consumption Value Market Share by Application (2019-2024)
5.2 Global Biosimilar Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biosimilar Consumption Value by Type (2019-2030)
6.2 North America Biosimilar Consumption Value by Application (2019-2030)
6.3 North America Biosimilar Market Size by Country
6.3.1 North America Biosimilar Consumption Value by Country (2019-2030)
6.3.2 United States Biosimilar Market Size and Forecast (2019-2030)
6.3.3 Canada Biosimilar Market Size and Forecast (2019-2030)
6.3.4 Mexico Biosimilar Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biosimilar Consumption Value by Type (2019-2030)
7.2 Europe Biosimilar Consumption Value by Application (2019-2030)
7.3 Europe Biosimilar Market Size by Country
7.3.1 Europe Biosimilar Consumption Value by Country (2019-2030)
7.3.2 Germany Biosimilar Market Size and Forecast (2019-2030)
7.3.3 France Biosimilar Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biosimilar Market Size and Forecast (2019-2030)
7.3.5 Russia Biosimilar Market Size and Forecast (2019-2030)
7.3.6 Italy Biosimilar Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilar Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biosimilar Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biosimilar Market Size by Region
8.3.1 Asia-Pacific Biosimilar Consumption Value by Region (2019-2030)
8.3.2 China Biosimilar Market Size and Forecast (2019-2030)
8.3.3 Japan Biosimilar Market Size and Forecast (2019-2030)
8.3.4 South Korea Biosimilar Market Size and Forecast (2019-2030)
8.3.5 India Biosimilar Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biosimilar Market Size and Forecast (2019-2030)
8.3.7 Australia Biosimilar Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biosimilar Consumption Value by Type (2019-2030)
9.2 South America Biosimilar Consumption Value by Application (2019-2030)
9.3 South America Biosimilar Market Size by Country
9.3.1 South America Biosimilar Consumption Value by Country (2019-2030)
9.3.2 Brazil Biosimilar Market Size and Forecast (2019-2030)
9.3.3 Argentina Biosimilar Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilar Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biosimilar Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biosimilar Market Size by Country
10.3.1 Middle East & Africa Biosimilar Consumption Value by Country (2019-2030)
10.3.2 Turkey Biosimilar Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biosimilar Market Size and Forecast (2019-2030)
10.3.4 UAE Biosimilar Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biosimilar Market Drivers
11.2 Biosimilar Market Restraints
11.3 Biosimilar Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilar Industry Chain
12.2 Biosimilar Upstream Analysis
12.3 Biosimilar Midstream Analysis
12.4 Biosimilar Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biosimilar
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilar by Type
1.3.1 Overview: Global Biosimilar Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biosimilar Consumption Value Market Share by Type in 2023
1.3.3 Biosimilar Monoclonal Antibodies
1.3.4 Biosimilar Insulin
1.3.5 Others
1.4 Global Biosimilar Market by Application
1.4.1 Overview: Global Biosimilar Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer
1.4.3 Immunological Diseases
1.4.4 Diabetes
1.4.5 Others
1.5 Global Biosimilar Market Size & Forecast
1.6 Global Biosimilar Market Size and Forecast by Region
1.6.1 Global Biosimilar Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biosimilar Market Size by Region, (2019-2030)
1.6.3 North America Biosimilar Market Size and Prospect (2019-2030)
1.6.4 Europe Biosimilar Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biosimilar Market Size and Prospect (2019-2030)
1.6.6 South America Biosimilar Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biosimilar Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biosimilar Product and Solutions
2.1.4 Pfizer Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biosimilar Product and Solutions
2.2.4 Amgen Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Biosimilar Product and Solutions
2.3.4 Biogen Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Biosimilar Product and Solutions
2.4.4 Novartis Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Samsung Bioepis
2.5.1 Samsung Bioepis Details
2.5.2 Samsung Bioepis Major Business
2.5.3 Samsung Bioepis Biosimilar Product and Solutions
2.5.4 Samsung Bioepis Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Samsung Bioepis Recent Developments and Future Plans
2.6 Viatris
2.6.1 Viatris Details
2.6.2 Viatris Major Business
2.6.3 Viatris Biosimilar Product and Solutions
2.6.4 Viatris Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Viatris Recent Developments and Future Plans
2.7 Fresenius Kabi
2.7.1 Fresenius Kabi Details
2.7.2 Fresenius Kabi Major Business
2.7.3 Fresenius Kabi Biosimilar Product and Solutions
2.7.4 Fresenius Kabi Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Fresenius Kabi Recent Developments and Future Plans
2.8 Celltrion
2.8.1 Celltrion Details
2.8.2 Celltrion Major Business
2.8.3 Celltrion Biosimilar Product and Solutions
2.8.4 Celltrion Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Celltrion Recent Developments and Future Plans
2.9 Cadila Healthcare
2.9.1 Cadila Healthcare Details
2.9.2 Cadila Healthcare Major Business
2.9.3 Cadila Healthcare Biosimilar Product and Solutions
2.9.4 Cadila Healthcare Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Cadila Healthcare Recent Developments and Future Plans
2.10 Torrent Pharmaceuticals
2.10.1 Torrent Pharmaceuticals Details
2.10.2 Torrent Pharmaceuticals Major Business
2.10.3 Torrent Pharmaceuticals Biosimilar Product and Solutions
2.10.4 Torrent Pharmaceuticals Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Torrent Pharmaceuticals Recent Developments and Future Plans
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim Biosimilar Product and Solutions
2.11.4 Boehringer Ingelheim Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Boehringer Ingelheim Recent Developments and Future Plans
2.12 Qilu Pharmaceutical
2.12.1 Qilu Pharmaceutical Details
2.12.2 Qilu Pharmaceutical Major Business
2.12.3 Qilu Pharmaceutical Biosimilar Product and Solutions
2.12.4 Qilu Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Qilu Pharmaceutical Recent Developments and Future Plans
2.13 Bio-Thera
2.13.1 Bio-Thera Details
2.13.2 Bio-Thera Major Business
2.13.3 Bio-Thera Biosimilar Product and Solutions
2.13.4 Bio-Thera Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Bio-Thera Recent Developments and Future Plans
2.14 Zhejiang Hisun
2.14.1 Zhejiang Hisun Details
2.14.2 Zhejiang Hisun Major Business
2.14.3 Zhejiang Hisun Biosimilar Product and Solutions
2.14.4 Zhejiang Hisun Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Zhejiang Hisun Recent Developments and Future Plans
2.15 Shanghai Henlius
2.15.1 Shanghai Henlius Details
2.15.2 Shanghai Henlius Major Business
2.15.3 Shanghai Henlius Biosimilar Product and Solutions
2.15.4 Shanghai Henlius Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Shanghai Henlius Recent Developments and Future Plans
2.16 Innovent Biologics
2.16.1 Innovent Biologics Details
2.16.2 Innovent Biologics Major Business
2.16.3 Innovent Biologics Biosimilar Product and Solutions
2.16.4 Innovent Biologics Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Innovent Biologics Recent Developments and Future Plans
2.17 Jiangsu Hengrui
2.17.1 Jiangsu Hengrui Details
2.17.2 Jiangsu Hengrui Major Business
2.17.3 Jiangsu Hengrui Biosimilar Product and Solutions
2.17.4 Jiangsu Hengrui Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Jiangsu Hengrui Recent Developments and Future Plans
2.18 Gan&Lee
2.18.1 Gan&Lee Details
2.18.2 Gan&Lee Major Business
2.18.3 Gan&Lee Biosimilar Product and Solutions
2.18.4 Gan&Lee Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Gan&Lee Recent Developments and Future Plans
2.19 Tonghua Dongbao
2.19.1 Tonghua Dongbao Details
2.19.2 Tonghua Dongbao Major Business
2.19.3 Tonghua Dongbao Biosimilar Product and Solutions
2.19.4 Tonghua Dongbao Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Tonghua Dongbao Recent Developments and Future Plans
2.20 United Laboratory
2.20.1 United Laboratory Details
2.20.2 United Laboratory Major Business
2.20.3 United Laboratory Biosimilar Product and Solutions
2.20.4 United Laboratory Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 United Laboratory Recent Developments and Future Plans
2.21 3SBIO
2.21.1 3SBIO Details
2.21.2 3SBIO Major Business
2.21.3 3SBIO Biosimilar Product and Solutions
2.21.4 3SBIO Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 3SBIO Recent Developments and Future Plans
2.22 Luye Pharma
2.22.1 Luye Pharma Details
2.22.2 Luye Pharma Major Business
2.22.3 Luye Pharma Biosimilar Product and Solutions
2.22.4 Luye Pharma Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Luye Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilar Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biosimilar by Company Revenue
3.2.2 Top 3 Biosimilar Players Market Share in 2023
3.2.3 Top 6 Biosimilar Players Market Share in 2023
3.3 Biosimilar Market: Overall Company Footprint Analysis
3.3.1 Biosimilar Market: Region Footprint
3.3.2 Biosimilar Market: Company Product Type Footprint
3.3.3 Biosimilar Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilar Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biosimilar Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilar Consumption Value Market Share by Application (2019-2024)
5.2 Global Biosimilar Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biosimilar Consumption Value by Type (2019-2030)
6.2 North America Biosimilar Consumption Value by Application (2019-2030)
6.3 North America Biosimilar Market Size by Country
6.3.1 North America Biosimilar Consumption Value by Country (2019-2030)
6.3.2 United States Biosimilar Market Size and Forecast (2019-2030)
6.3.3 Canada Biosimilar Market Size and Forecast (2019-2030)
6.3.4 Mexico Biosimilar Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biosimilar Consumption Value by Type (2019-2030)
7.2 Europe Biosimilar Consumption Value by Application (2019-2030)
7.3 Europe Biosimilar Market Size by Country
7.3.1 Europe Biosimilar Consumption Value by Country (2019-2030)
7.3.2 Germany Biosimilar Market Size and Forecast (2019-2030)
7.3.3 France Biosimilar Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biosimilar Market Size and Forecast (2019-2030)
7.3.5 Russia Biosimilar Market Size and Forecast (2019-2030)
7.3.6 Italy Biosimilar Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilar Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biosimilar Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biosimilar Market Size by Region
8.3.1 Asia-Pacific Biosimilar Consumption Value by Region (2019-2030)
8.3.2 China Biosimilar Market Size and Forecast (2019-2030)
8.3.3 Japan Biosimilar Market Size and Forecast (2019-2030)
8.3.4 South Korea Biosimilar Market Size and Forecast (2019-2030)
8.3.5 India Biosimilar Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biosimilar Market Size and Forecast (2019-2030)
8.3.7 Australia Biosimilar Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biosimilar Consumption Value by Type (2019-2030)
9.2 South America Biosimilar Consumption Value by Application (2019-2030)
9.3 South America Biosimilar Market Size by Country
9.3.1 South America Biosimilar Consumption Value by Country (2019-2030)
9.3.2 Brazil Biosimilar Market Size and Forecast (2019-2030)
9.3.3 Argentina Biosimilar Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilar Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biosimilar Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biosimilar Market Size by Country
10.3.1 Middle East & Africa Biosimilar Consumption Value by Country (2019-2030)
10.3.2 Turkey Biosimilar Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biosimilar Market Size and Forecast (2019-2030)
10.3.4 UAE Biosimilar Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biosimilar Market Drivers
11.2 Biosimilar Market Restraints
11.3 Biosimilar Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilar Industry Chain
12.2 Biosimilar Upstream Analysis
12.3 Biosimilar Midstream Analysis
12.4 Biosimilar Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biosimilar Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilar Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biosimilar Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biosimilar Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Biosimilar Product and Solutions
Table 8. Pfizer Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Amgen Company Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Biosimilar Product and Solutions
Table 13. Amgen Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Amgen Recent Developments and Future Plans
Table 15. Biogen Company Information, Head Office, and Major Competitors
Table 16. Biogen Major Business
Table 17. Biogen Biosimilar Product and Solutions
Table 18. Biogen Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Biogen Recent Developments and Future Plans
Table 20. Novartis Company Information, Head Office, and Major Competitors
Table 21. Novartis Major Business
Table 22. Novartis Biosimilar Product and Solutions
Table 23. Novartis Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novartis Recent Developments and Future Plans
Table 25. Samsung Bioepis Company Information, Head Office, and Major Competitors
Table 26. Samsung Bioepis Major Business
Table 27. Samsung Bioepis Biosimilar Product and Solutions
Table 28. Samsung Bioepis Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Samsung Bioepis Recent Developments and Future Plans
Table 30. Viatris Company Information, Head Office, and Major Competitors
Table 31. Viatris Major Business
Table 32. Viatris Biosimilar Product and Solutions
Table 33. Viatris Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Viatris Recent Developments and Future Plans
Table 35. Fresenius Kabi Company Information, Head Office, and Major Competitors
Table 36. Fresenius Kabi Major Business
Table 37. Fresenius Kabi Biosimilar Product and Solutions
Table 38. Fresenius Kabi Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Fresenius Kabi Recent Developments and Future Plans
Table 40. Celltrion Company Information, Head Office, and Major Competitors
Table 41. Celltrion Major Business
Table 42. Celltrion Biosimilar Product and Solutions
Table 43. Celltrion Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Celltrion Recent Developments and Future Plans
Table 45. Cadila Healthcare Company Information, Head Office, and Major Competitors
Table 46. Cadila Healthcare Major Business
Table 47. Cadila Healthcare Biosimilar Product and Solutions
Table 48. Cadila Healthcare Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Cadila Healthcare Recent Developments and Future Plans
Table 50. Torrent Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. Torrent Pharmaceuticals Major Business
Table 52. Torrent Pharmaceuticals Biosimilar Product and Solutions
Table 53. Torrent Pharmaceuticals Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Torrent Pharmaceuticals Recent Developments and Future Plans
Table 55. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 56. Boehringer Ingelheim Major Business
Table 57. Boehringer Ingelheim Biosimilar Product and Solutions
Table 58. Boehringer Ingelheim Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Boehringer Ingelheim Recent Developments and Future Plans
Table 60. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 61. Qilu Pharmaceutical Major Business
Table 62. Qilu Pharmaceutical Biosimilar Product and Solutions
Table 63. Qilu Pharmaceutical Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Qilu Pharmaceutical Recent Developments and Future Plans
Table 65. Bio-Thera Company Information, Head Office, and Major Competitors
Table 66. Bio-Thera Major Business
Table 67. Bio-Thera Biosimilar Product and Solutions
Table 68. Bio-Thera Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Bio-Thera Recent Developments and Future Plans
Table 70. Zhejiang Hisun Company Information, Head Office, and Major Competitors
Table 71. Zhejiang Hisun Major Business
Table 72. Zhejiang Hisun Biosimilar Product and Solutions
Table 73. Zhejiang Hisun Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Zhejiang Hisun Recent Developments and Future Plans
Table 75. Shanghai Henlius Company Information, Head Office, and Major Competitors
Table 76. Shanghai Henlius Major Business
Table 77. Shanghai Henlius Biosimilar Product and Solutions
Table 78. Shanghai Henlius Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Shanghai Henlius Recent Developments and Future Plans
Table 80. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 81. Innovent Biologics Major Business
Table 82. Innovent Biologics Biosimilar Product and Solutions
Table 83. Innovent Biologics Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Innovent Biologics Recent Developments and Future Plans
Table 85. Jiangsu Hengrui Company Information, Head Office, and Major Competitors
Table 86. Jiangsu Hengrui Major Business
Table 87. Jiangsu Hengrui Biosimilar Product and Solutions
Table 88. Jiangsu Hengrui Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Jiangsu Hengrui Recent Developments and Future Plans
Table 90. Gan&Lee Company Information, Head Office, and Major Competitors
Table 91. Gan&Lee Major Business
Table 92. Gan&Lee Biosimilar Product and Solutions
Table 93. Gan&Lee Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Gan&Lee Recent Developments and Future Plans
Table 95. Tonghua Dongbao Company Information, Head Office, and Major Competitors
Table 96. Tonghua Dongbao Major Business
Table 97. Tonghua Dongbao Biosimilar Product and Solutions
Table 98. Tonghua Dongbao Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Tonghua Dongbao Recent Developments and Future Plans
Table 100. United Laboratory Company Information, Head Office, and Major Competitors
Table 101. United Laboratory Major Business
Table 102. United Laboratory Biosimilar Product and Solutions
Table 103. United Laboratory Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. United Laboratory Recent Developments and Future Plans
Table 105. 3SBIO Company Information, Head Office, and Major Competitors
Table 106. 3SBIO Major Business
Table 107. 3SBIO Biosimilar Product and Solutions
Table 108. 3SBIO Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. 3SBIO Recent Developments and Future Plans
Table 110. Luye Pharma Company Information, Head Office, and Major Competitors
Table 111. Luye Pharma Major Business
Table 112. Luye Pharma Biosimilar Product and Solutions
Table 113. Luye Pharma Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Luye Pharma Recent Developments and Future Plans
Table 115. Global Biosimilar Revenue (USD Million) by Players (2019-2024)
Table 116. Global Biosimilar Revenue Share by Players (2019-2024)
Table 117. Breakdown of Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 119. Head Office of Key Biosimilar Players
Table 120. Biosimilar Market: Company Product Type Footprint
Table 121. Biosimilar Market: Company Product Application Footprint
Table 122. Biosimilar New Market Entrants and Barriers to Market Entry
Table 123. Biosimilar Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Biosimilar Consumption Value (USD Million) by Type (2019-2024)
Table 125. Global Biosimilar Consumption Value Share by Type (2019-2024)
Table 126. Global Biosimilar Consumption Value Forecast by Type (2025-2030)
Table 127. Global Biosimilar Consumption Value by Application (2019-2024)
Table 128. Global Biosimilar Consumption Value Forecast by Application (2025-2030)
Table 129. North America Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 130. North America Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 131. North America Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 132. North America Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 133. North America Biosimilar Consumption Value by Country (2019-2024) & (USD Million)
Table 134. North America Biosimilar Consumption Value by Country (2025-2030) & (USD Million)
Table 135. Europe Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Europe Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Europe Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 138. Europe Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 139. Europe Biosimilar Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe Biosimilar Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 142. Asia-Pacific Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 143. Asia-Pacific Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 144. Asia-Pacific Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 145. Asia-Pacific Biosimilar Consumption Value by Region (2019-2024) & (USD Million)
Table 146. Asia-Pacific Biosimilar Consumption Value by Region (2025-2030) & (USD Million)
Table 147. South America Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 148. South America Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 149. South America Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 150. South America Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 151. South America Biosimilar Consumption Value by Country (2019-2024) & (USD Million)
Table 152. South America Biosimilar Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Middle East & Africa Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 154. Middle East & Africa Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 155. Middle East & Africa Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 156. Middle East & Africa Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 157. Middle East & Africa Biosimilar Consumption Value by Country (2019-2024) & (USD Million)
Table 158. Middle East & Africa Biosimilar Consumption Value by Country (2025-2030) & (USD Million)
Table 159. Biosimilar Raw Material
Table 160. Key Suppliers of Biosimilar Raw Materials
Table 1. Global Biosimilar Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilar Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biosimilar Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biosimilar Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Biosimilar Product and Solutions
Table 8. Pfizer Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Amgen Company Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Biosimilar Product and Solutions
Table 13. Amgen Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Amgen Recent Developments and Future Plans
Table 15. Biogen Company Information, Head Office, and Major Competitors
Table 16. Biogen Major Business
Table 17. Biogen Biosimilar Product and Solutions
Table 18. Biogen Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Biogen Recent Developments and Future Plans
Table 20. Novartis Company Information, Head Office, and Major Competitors
Table 21. Novartis Major Business
Table 22. Novartis Biosimilar Product and Solutions
Table 23. Novartis Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novartis Recent Developments and Future Plans
Table 25. Samsung Bioepis Company Information, Head Office, and Major Competitors
Table 26. Samsung Bioepis Major Business
Table 27. Samsung Bioepis Biosimilar Product and Solutions
Table 28. Samsung Bioepis Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Samsung Bioepis Recent Developments and Future Plans
Table 30. Viatris Company Information, Head Office, and Major Competitors
Table 31. Viatris Major Business
Table 32. Viatris Biosimilar Product and Solutions
Table 33. Viatris Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Viatris Recent Developments and Future Plans
Table 35. Fresenius Kabi Company Information, Head Office, and Major Competitors
Table 36. Fresenius Kabi Major Business
Table 37. Fresenius Kabi Biosimilar Product and Solutions
Table 38. Fresenius Kabi Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Fresenius Kabi Recent Developments and Future Plans
Table 40. Celltrion Company Information, Head Office, and Major Competitors
Table 41. Celltrion Major Business
Table 42. Celltrion Biosimilar Product and Solutions
Table 43. Celltrion Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Celltrion Recent Developments and Future Plans
Table 45. Cadila Healthcare Company Information, Head Office, and Major Competitors
Table 46. Cadila Healthcare Major Business
Table 47. Cadila Healthcare Biosimilar Product and Solutions
Table 48. Cadila Healthcare Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Cadila Healthcare Recent Developments and Future Plans
Table 50. Torrent Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. Torrent Pharmaceuticals Major Business
Table 52. Torrent Pharmaceuticals Biosimilar Product and Solutions
Table 53. Torrent Pharmaceuticals Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Torrent Pharmaceuticals Recent Developments and Future Plans
Table 55. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 56. Boehringer Ingelheim Major Business
Table 57. Boehringer Ingelheim Biosimilar Product and Solutions
Table 58. Boehringer Ingelheim Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Boehringer Ingelheim Recent Developments and Future Plans
Table 60. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 61. Qilu Pharmaceutical Major Business
Table 62. Qilu Pharmaceutical Biosimilar Product and Solutions
Table 63. Qilu Pharmaceutical Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Qilu Pharmaceutical Recent Developments and Future Plans
Table 65. Bio-Thera Company Information, Head Office, and Major Competitors
Table 66. Bio-Thera Major Business
Table 67. Bio-Thera Biosimilar Product and Solutions
Table 68. Bio-Thera Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Bio-Thera Recent Developments and Future Plans
Table 70. Zhejiang Hisun Company Information, Head Office, and Major Competitors
Table 71. Zhejiang Hisun Major Business
Table 72. Zhejiang Hisun Biosimilar Product and Solutions
Table 73. Zhejiang Hisun Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Zhejiang Hisun Recent Developments and Future Plans
Table 75. Shanghai Henlius Company Information, Head Office, and Major Competitors
Table 76. Shanghai Henlius Major Business
Table 77. Shanghai Henlius Biosimilar Product and Solutions
Table 78. Shanghai Henlius Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Shanghai Henlius Recent Developments and Future Plans
Table 80. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 81. Innovent Biologics Major Business
Table 82. Innovent Biologics Biosimilar Product and Solutions
Table 83. Innovent Biologics Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Innovent Biologics Recent Developments and Future Plans
Table 85. Jiangsu Hengrui Company Information, Head Office, and Major Competitors
Table 86. Jiangsu Hengrui Major Business
Table 87. Jiangsu Hengrui Biosimilar Product and Solutions
Table 88. Jiangsu Hengrui Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Jiangsu Hengrui Recent Developments and Future Plans
Table 90. Gan&Lee Company Information, Head Office, and Major Competitors
Table 91. Gan&Lee Major Business
Table 92. Gan&Lee Biosimilar Product and Solutions
Table 93. Gan&Lee Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Gan&Lee Recent Developments and Future Plans
Table 95. Tonghua Dongbao Company Information, Head Office, and Major Competitors
Table 96. Tonghua Dongbao Major Business
Table 97. Tonghua Dongbao Biosimilar Product and Solutions
Table 98. Tonghua Dongbao Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Tonghua Dongbao Recent Developments and Future Plans
Table 100. United Laboratory Company Information, Head Office, and Major Competitors
Table 101. United Laboratory Major Business
Table 102. United Laboratory Biosimilar Product and Solutions
Table 103. United Laboratory Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. United Laboratory Recent Developments and Future Plans
Table 105. 3SBIO Company Information, Head Office, and Major Competitors
Table 106. 3SBIO Major Business
Table 107. 3SBIO Biosimilar Product and Solutions
Table 108. 3SBIO Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. 3SBIO Recent Developments and Future Plans
Table 110. Luye Pharma Company Information, Head Office, and Major Competitors
Table 111. Luye Pharma Major Business
Table 112. Luye Pharma Biosimilar Product and Solutions
Table 113. Luye Pharma Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Luye Pharma Recent Developments and Future Plans
Table 115. Global Biosimilar Revenue (USD Million) by Players (2019-2024)
Table 116. Global Biosimilar Revenue Share by Players (2019-2024)
Table 117. Breakdown of Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 119. Head Office of Key Biosimilar Players
Table 120. Biosimilar Market: Company Product Type Footprint
Table 121. Biosimilar Market: Company Product Application Footprint
Table 122. Biosimilar New Market Entrants and Barriers to Market Entry
Table 123. Biosimilar Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Biosimilar Consumption Value (USD Million) by Type (2019-2024)
Table 125. Global Biosimilar Consumption Value Share by Type (2019-2024)
Table 126. Global Biosimilar Consumption Value Forecast by Type (2025-2030)
Table 127. Global Biosimilar Consumption Value by Application (2019-2024)
Table 128. Global Biosimilar Consumption Value Forecast by Application (2025-2030)
Table 129. North America Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 130. North America Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 131. North America Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 132. North America Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 133. North America Biosimilar Consumption Value by Country (2019-2024) & (USD Million)
Table 134. North America Biosimilar Consumption Value by Country (2025-2030) & (USD Million)
Table 135. Europe Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Europe Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Europe Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 138. Europe Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 139. Europe Biosimilar Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe Biosimilar Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 142. Asia-Pacific Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 143. Asia-Pacific Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 144. Asia-Pacific Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 145. Asia-Pacific Biosimilar Consumption Value by Region (2019-2024) & (USD Million)
Table 146. Asia-Pacific Biosimilar Consumption Value by Region (2025-2030) & (USD Million)
Table 147. South America Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 148. South America Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 149. South America Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 150. South America Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 151. South America Biosimilar Consumption Value by Country (2019-2024) & (USD Million)
Table 152. South America Biosimilar Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Middle East & Africa Biosimilar Consumption Value by Type (2019-2024) & (USD Million)
Table 154. Middle East & Africa Biosimilar Consumption Value by Type (2025-2030) & (USD Million)
Table 155. Middle East & Africa Biosimilar Consumption Value by Application (2019-2024) & (USD Million)
Table 156. Middle East & Africa Biosimilar Consumption Value by Application (2025-2030) & (USD Million)
Table 157. Middle East & Africa Biosimilar Consumption Value by Country (2019-2024) & (USD Million)
Table 158. Middle East & Africa Biosimilar Consumption Value by Country (2025-2030) & (USD Million)
Table 159. Biosimilar Raw Material
Table 160. Key Suppliers of Biosimilar Raw Materials
LIST OF FIGURES
Figure 1. Biosimilar Picture
Figure 2. Global Biosimilar Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilar Consumption Value Market Share by Type in 2023
Figure 4. Biosimilar Monoclonal Antibodies
Figure 5. Biosimilar Insulin
Figure 6. Others
Figure 7. Global Biosimilar Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Biosimilar Consumption Value Market Share by Application in 2023
Figure 9. Cancer Picture
Figure 10. Immunological Diseases Picture
Figure 11. Diabetes Picture
Figure 12. Others Picture
Figure 13. Global Biosimilar Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Biosimilar Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Biosimilar Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Biosimilar Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Biosimilar Consumption Value Market Share by Region in 2023
Figure 18. North America Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Biosimilar Revenue Share by Players in 2023
Figure 24. Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Biosimilar Market Share in 2023
Figure 26. Global Top 6 Players Biosimilar Market Share in 2023
Figure 27. Global Biosimilar Consumption Value Share by Type (2019-2024)
Figure 28. Global Biosimilar Market Share Forecast by Type (2025-2030)
Figure 29. Global Biosimilar Consumption Value Share by Application (2019-2024)
Figure 30. Global Biosimilar Market Share Forecast by Application (2025-2030)
Figure 31. North America Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Biosimilar Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Biosimilar Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 41. France Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Biosimilar Consumption Value Market Share by Region (2019-2030)
Figure 48. China Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 51. India Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Biosimilar Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Biosimilar Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 65. Biosimilar Market Drivers
Figure 66. Biosimilar Market Restraints
Figure 67. Biosimilar Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Biosimilar in 2023
Figure 70. Manufacturing Process Analysis of Biosimilar
Figure 71. Biosimilar Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Biosimilar Picture
Figure 2. Global Biosimilar Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilar Consumption Value Market Share by Type in 2023
Figure 4. Biosimilar Monoclonal Antibodies
Figure 5. Biosimilar Insulin
Figure 6. Others
Figure 7. Global Biosimilar Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Biosimilar Consumption Value Market Share by Application in 2023
Figure 9. Cancer Picture
Figure 10. Immunological Diseases Picture
Figure 11. Diabetes Picture
Figure 12. Others Picture
Figure 13. Global Biosimilar Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Biosimilar Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Biosimilar Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Biosimilar Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Biosimilar Consumption Value Market Share by Region in 2023
Figure 18. North America Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Biosimilar Revenue Share by Players in 2023
Figure 24. Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Biosimilar Market Share in 2023
Figure 26. Global Top 6 Players Biosimilar Market Share in 2023
Figure 27. Global Biosimilar Consumption Value Share by Type (2019-2024)
Figure 28. Global Biosimilar Market Share Forecast by Type (2025-2030)
Figure 29. Global Biosimilar Consumption Value Share by Application (2019-2024)
Figure 30. Global Biosimilar Market Share Forecast by Application (2025-2030)
Figure 31. North America Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Biosimilar Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Biosimilar Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 41. France Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Biosimilar Consumption Value Market Share by Region (2019-2030)
Figure 48. China Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 51. India Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Biosimilar Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Biosimilar Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Biosimilar Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Biosimilar Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Biosimilar Consumption Value (2019-2030) & (USD Million)
Figure 65. Biosimilar Market Drivers
Figure 66. Biosimilar Market Restraints
Figure 67. Biosimilar Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Biosimilar in 2023
Figure 70. Manufacturing Process Analysis of Biosimilar
Figure 71. Biosimilar Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
